Systematic Cellular Disease Models Reveal Synergistic Interaction of Trisomy 21 and GATA1 Mutations in Hematopoietic AbnormalitiesKimihiko Banno, Keiichi Ozono, Sayaka Omori et al.|Cell Reports|2016Cited by 102
Preserved High Probability of Overall Survival with Significant Reduction of Chemotherapy for Myeloid Leukemia in Down Syndrome: A Nationwide Prospective Study in JapanTakashi Taga, Souichi Adachi, Tomoyuki Watanabe et al.|Pediatric Blood & Cancer|2015Cited by 48
Resistance of t(17;19)‐acute lymphoblastic leukemia cell lines to multiagents in induction therapyAtsushi Watanabe, Kanji Sugita, Junko Takita et al.|Cancer Medicine|2019Cited by 22
Post-induction MRD by FCM and GATA1-PCR are significant prognostic factors for myeloid leukemia of Down syndromeTakashi Taga, Daisuke Tomizawa, Shiro Tanaka et al.|Leukemia|2021Cited by 19
Transient myeloproliferative disorder with partial trisomy 21Takahide Takahashi, Akira Shimada, Akira Inoue et al.|Pediatric Blood & Cancer|2015Cited by 6